Research Article| Volume 58, ISSUE 1, P75-78, January 2020

Percutaneous cryoablation of benign bony tumours of the mandible

Published:November 14, 2019DOI:


      Treatment of bony tumours of the oral and maxillofacial area usually involve resection. However, access to certain areas may be difficult because of the size or site of the tumour. A poor view of the lesion during operation is another limiting factor, which can lead to incomplete resection in difficult cases. Percutaneous cryoablation is a common procedure for treating benign and malignant bony lesions outside the oral and maxillofacial area, but has to our knowledge never been used as a stand-alone treatment as we describe here. In 2016, three patients with benign bony tumours of the mandible (one a keratocyst, one an angiofibroma, and one a giant cell granuloma) were treated with one session of percutaneous cryoablation. Outcomes were monitored with computed tomography or magnetic resonance imaging at one year. No patient had a procedure-related complication, and there were no other complications. Radiological controls showed complete recovery. Percutaneous cryoablation seems to be an interesting and valuable alternative to resection for bony lesions with its limited access and high operative morbidity.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Arnott J.
        On the treatment of cancer by regulated application of an anaesthetic temperature.
        J Churchill, London1851 (32)
        • Emmings F.G.
        • Neiders M.E.
        • Green Jr., G.W.
        • et al.
        Freezing of the mandible without excision.
        J Oral Maxillofac Surg. 1966; 24: 145-155
        • Marcove R.C.
        • Miller T.R.
        Treatment of primary and metastatic bone tumors by cryosurgery.
        JAMA. 1969; 207: 1890-1894
        • Sippel H.W.
        • Emmings F.G.
        Cryotherapy in the treatment of recurrent ossifying fibroma: report of a case.
        J Oral Surg. 1969; 27: 32-35
        • Pogrel M.A.
        The use of liquid nitrogen cryotherapy in the management of locally aggressive bone lesions.
        J Oral Maxillofac Surg. 1993; 31: 264-274
        • Sampson D.E.
        • Pogrel M.A.
        Management of mandibular ameloblastoma: the clinical basis for a treatment algorithm.
        J Oral Maxillofac Surg. 1999; 57: 1074-1079
        • Fregnani E.R.
        • da Cruz Perez D.E.
        • de Almeida O.P.
        • et al.
        Clinicopahtological study and treatment outcomes of 121 cases of ameloblastomas.
        Int J Oral Maxillofac Surg. 2010; 39: 145-149
        • Salmassy D.A.
        • Pogrel M.A.
        Liquid nitrogen crysurgery and immediate bone grafting in the management of aggressive primary jaw lesions.
        J Oral Maxillofac Surg. 1995; 53: 784-790
        • Carneiro J.T.
        Management of locally aggressive mandibular tumours using a gas combination cryosurgery.
        J Craniomaxillofac Surg. 2014; 42: 423-427
        • Al-Moraissi E.A.
        • Dahan A.A.
        • Alwadeai M.A.
        • et al.
        What surgical treatment has the lowest recurrence rate following the management of keratocystic odontogenic tumor? A large systematic review and meta-analysis.
        J Craniomaxillofac Surg. 2017; 45: 131-144
        • Tonietto L.
        Enucleation and liquid nitrogen cryotherapy in the treatment of keratocystic odontogenic tumors: a case series.
        J Oral Maxillofac Surg. 2011; 69: e112-e117
        • Johnson N.R.
        Management and recurrence of keratocystic odontogenic tumor: a systematic review.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; 116: e271-e276
        • Deschamps F.
        • Farouil G.
        • de Baere T.
        Percutaneous ablation of bone tumors.
        Diagn Interv Imaging. 2014; 95: 659-663
        • Gage A.A.
        • Baust J.M.
        • Baust J.G.
        Experimental cryosurgery investigations in vivo.
        Cryobiology. 2009; 59: 229-243
        • Voorsmit R.A.
        • Stoelinga P.J.
        • Van Haelst U.J.
        The management of keratocysts.
        J Maxillofac Surg. 1981; 9: 228-236
        • Fisher A.D.
        • Williams D.F.
        • Bradley P.F.
        The effect of cryosurgery on the strength of bone.
        Br J Oral Surg. 1978; 15: 215-222
        • Chen C.
        • Garlich J.
        • Vincent K.
        • et al.
        Postoperative complications with cryotherapy in bone tumors.
        J Bone Oncol. 2017; 7: 13-17
        • Thompson R.H.
        • Atwell T.
        • Schmit G.
        • et al.
        Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
        Eur Urol. 2015; 67: 252-259
        • Gage A.A.
        • Greene Jr., G.W.
        • Neiders M.E.
        • et al.
        Freeezing bone without excision. An experimental study of bone-cell destruction and manner of regrowth in dogs.
        JAMA. 1966; 196: 770-774
        • Bickels J.
        • Kollender Y.
        • Merimsky O.
        • et al.
        Closed argon-based cryoablation of bone tumours.
        J Bone Joint Surg Br. 2004; 86: 714-718